? ÊàŦÑ×£¨Arthritis£©
? ¼¡Î®ËõÐÔ¼¹Ëè²àË÷Ó²»¯Ö¢£¨Amyotrophic Lateral Sclerosis, ALS£©
? Òøм²¡£¨Psoriasis£©
? ÌØÓ¦ÐÔƤÑ×£¨Atopic Dermatitis, AD£©
? Ñ×Ö¢ÐÔ³¦²¡£¨Inflammatory Bowel Disease, IBD£©
01 ½ºÔÓÕµ¼µÄÊàŦÑ×Ä£ÐÍ
Àà·çʪÐÔÊàŦÑ×£¨Rheumatoid Arthritis, RA£©¶¯ÎïÄ£Ð͹ØÓÚÑо¿ÌåÄÚRAµÄ·¢²¡»úÖƺÍÆÀ¼Û¿¹RAÒ©ÎïµÄÁÆЧÖÁ¹ØÖØÒª¡£
½ºÔÓÕµ¼µÄÊàŦÑ×£¨Collagen Induced Arthritis, CIA£©ÓëÈËÀàÀà·çʪÊàŦÑ×¾ßÓÐÅäºÏµÄÃâÒßѧºÍ²¡ÀíѧÌØÕ÷£¬Òò´Ë±»¹ã·ºÓ¦ÓÃÓÚÖ²¡»úÀíºÍÐÂҩҩЧµÄÑо¿¡£¢òÐͽºÔÂÑ°×£¨C¢ò£©Äܹ»ÃâÒßÓÕµ¼Ò׸ÐÄö³Ý¶¯ÎïºÍ·ÇÈËÁ鳤ÀදÎïÌåÄÚ±¬·¢ÊàŦÑ×ÐÔÖʵÄ×ÔÉíÃâÒß·´Ó¦¡£
±ðµÄ£¬CIAµÄÒ׸ÐÐÔÒ²ÓëRAÏàËÆ£¬ºÍÖ÷Òª×éÖ¯ÏàÈÝÐÔ¸´ºÏÌ壨Major Hhistocompatibility Complex, MHC£©µÄ¢òÀà·Ö×ÓÓйء£ÃâÒß·´Ó¦µÄÌصãÊÇ£º´Ì¼¤½ºÔÌØÒìÐÔTϸ°û£¬±¬·¢Õë¶ÔÐÔÃâÒß¿¹Ô£¨ÒìÔ´C¢ò£©ºÍ×ÔÉí¿¹Ô£¨Ð¡Êó»ò´óÊóC¢ò£©µÄ¸ßµÎ¶ÈÌØÒìÐÔ¿¹Ìå¡£
02 ÍêÈ«¸¥ÊÏ×ô¼ÁÓÕµ¼µÄÊàŦÑ×Ä£ÐÍ
Àà·çʪÐÔÊàŦÑ×£¨RA£©ÊÇÒ»ÖÖÂýÐÔ½øÐÐÐÔµÄÑ×Ö¢ÐÔÊàŦÑס£ÍêÈ«¸¥ÊÏ×ô¼Á£¨Complete Freund¡¯s Adjuvant, CFA£©ÓÕµ¼µÄÊàŦÑ×Ä£ÐÍÄܹ»ÌåÏÖ³ö°éÓÐÈ«ÉíÐԸıäµÄÁ¬ÐøÐÔÑ×Ö¢£¬ÒÔ¼°»¬Ä¤ÔöÉú¡¢½ÇĤÒí¡¢¶ú²¿ºÍβ²¿·ºÆð¡°ÊàŦÑס±½á½ÚµÈ£¬ÓëÈËÀàÊàŦÑ×ÓжàÖÖÏàËÆÖ®´¦£¬Òò´ËÊÇÒ»¸öºÜÊÇÊÊÊÊÓÃÓÚ·¢²¡»úÀíµÄÑо¿ºÍÐÂҩҩЧÆÀ¼ÛµÄÄ£ÐÍ¡£
CFAÊÇÓÉʯÀ¯ÓͺͶþËõ¸Ê¶´¼Ò»ÓÍËáÓëÈÈÃð»î½áºË·ÖÖ¦¸Ë¾ú»ìÏý¶ø³ÉµÄ»ìÏýÈéÒº£¬ÔÚÄö³ÝÀදÎïµÄצ²¿Æ¤ÏÂ×¢Éä»ò¸¹Ç»×¢É䣬´Ó¶øÓÕµ¼¶¯Îï¶àÆ÷¹ÙµÄÃâÒßÑ×Ö¢·´Ó¦¡£
CFAÓÕµ¼µÄ´óÊóÊàŦÑ×£¨Adjuvant Induced Arthritis, AIA£©Ó¦Óù㷺£¬¶ÔÑо¿Ñ×Ö¢Àú³ÌµÄ²¡Àí¡¢ÉúÀíºÍÒ©Àí×÷Óã¬ÒÔ¼°ÆÀ¹ÀÒ©ÎïµÄÕòʹDZÁ¦»ò¿¹Ñ××÷ÓþßÓÐÖØÒªÒâÒå¡£
03 ÄòËáÄÆÓÕµ¼µÄÍ´·çÐÔÊàŦÑ×Ä£ÐÍ
Í´·çÐÔÊàŦÑ×£¨Gouty Arthritis, GA£©µÄÖ÷ÒªÌØÕ÷ÊÇ£ºÄòËáÄÆ£¨Monosodium Urate, MSU£©¾§ÌåÔÚÊàŦÖÜΧ×éÖ¯³Á»ý£¬´Ì¼¤ÊàŦ£¬ÒýÆðÊàŦ»¬Ä¤¼°ÖÜΧ×éÖ¯²¡Ëð¼°Ñ×Ö¢·´Ó¦¡£ÁÙ´²ÖУ¬Í´·çµÄ·¢²¡Åãͬ×ÅÊàŦÖÜΧ×éÖ¯»òÊàŦµÄ´¥Í´¡¢ºì°ß¡¢·¢ºì¡¢Ö×ÕÍ¡¢ÌÛÍ´ºÍ·¢ÈÈ¡£
Ä¿Ç°£¬GA±¬·¢Ó뻺½âµÄ¾ßÌå»úÖÆÉÐδÃ÷È·£¬µ«Ñо¿ÈËÔ±ÆÕ±éÈÏΪ£¬ÊàŦ²¿Î»Îö³öµÄMSU¾§ÌåÊÇÔì³ÉÍ´·çÐÔÊàŦÑ×µÄÒªº¦»¯Ñ§ÎïÖÊ¡£MSU¾§ÌåÄܹ»ÓÕ·¢×ÔÉíÃâÒß¼°Ñ×Ö¢·´Ó¦£¬¹ú¼ÊÉϳ£±»ÓÃÓÚÓÕµ¼¼±ÐÔÍ´·çÐÔÊàŦÑ×Ä£ÐÍ£¬Òѱ»¹ã·ºÓ¦ÓÃÓÚÒ©Àí¡¢Ò©Ð§µÈ·½ÃæµÄÑо¿¡£
04 ʵÑéÐÔ×ÔÉíÃâÒßÐÔÄÔ¼¹ËèÑ×Ä£ÐÍ
¶à·¢ÐÔÓ²»¯Ö¢£¨Multiple Sclerosis, MS£©ÊÇÒ»ÖÖÖÐÊàÉñ¾ÏµÍ³£¨Central Nervous System, CNS£©µÄÑ×Ö¢ÐÔ¼²²¡£¬ÊµÑéÐÔ×ÔÉíÃâÒßÐÔÄÔ¼¹ËèÑ×£¨Experimental autoimmune encephalomyelitis, EAE£©ÊÇMS×î³£¼ûµÄ¶¯ÎïÄ£ÐÍÖ®Ò»¡£
MSµ¼ÖµÄÃâÒßϵͳ¹¥»÷»áʹËèÇÊÊÜËð£¬×ÌÈÅÉñ¾´«µ¼£¬½ø¶øµ¼ÖÂһϵÁÐÖ¢×´£¬°üÀ¨ÊÓÁ¦ÊÜËð¡¢¼¡ÈâÎÞÁ¦¡¢Ðµ÷ÄÜÁ¦È±Ê§ºÍÈÏÖª¹¦Ð§ÕÏ°¡£ÆäÌØÕ÷ÊÇÉñ¾Ñ×Ö¢¼°ÅãͬµÄÍÑËèÇʺÍÖáÍ»±äÐÔ¡£
ÔÚEAEСÊóÄ£ÐÍÖУ¬Í¨¹ýÓÕµ¼×ÔÉíÃâÒß·´Ó¦£¬Ê¹µÃTϸ°ûºÍµ¥ºËϸ°û½þÈó½øÈëÖÐÊàÉñ¾ÏµÍ³£¬µ¼ÖÂÖáÍ»µÄÈ¥ËèÇÊ»¯£¬½ø¶øÒýÆðÉñ¾´«µ¼ÕÏ°ºÍ½øÐÐÐÔºó̱֫»¾£¬Äܹ»Ä£ÄâMSµÄ²¡ÀíÌØÕ÷Óë¼²²¡½øÕ¹¡£
±ðµÄ£¬EAE³£±»ÓÃ×÷ϸ°û½éµ¼µÄÆ÷¹ÙÌØÒìÐÔ×ÔÉíÃâÒß¼²²¡Ä£ÐÍ¡£EAE»¹¾ßÓÐÅÓ´óµÄÉñ¾Ò©Àíѧ£¬Ðí¶àÓÃÓÚMSÒ©ÎﶼÊÇÔÚEAEÄ£Ð͵Ļù´¡ÉÏ¿ª·¢¡¢²âÊÔ¡¢ÑéÖ¤µÄ¡£
05 ßäàĪÌØÓÕµ¼µÄÒøм²¡Ä£ÐÍ
Òøм²¡ÊÇÒ»ÖÖÂýÐÔÑ×Ö¢ÐÔƤ·ô²¡£¬Óë×ÔÉíÃâÒß¹¦Ð§ÎÉÂҵȶàÖÖÓÕÒòÓйء£Òøм²¡»áµ¼ÖÂƤ·ôÉí·ÖµÄ¸Ä±ä£¬Ä¿Ç°ÆÕ±éÈÏΪÒøм²¡ÊÇÒ»ÖÖÃâÒßϸ°û¼°ÃâÒßÏà¹Øϸ°ûÅäºÏ½éµ¼µÄÑ×Ö¢ÐÔƤ·ô²¡¡£
ßäàĪÌØ£¨Imiquimod, IMQ£©ÓÕµ¼µÄСÊóÄ£ÐÍÊÇÊܵ½¹ã·ºÈϿɵÄÒøм²¡ÀදÎïÄ£ÐÍÖ®Ò»¡£IMQÊÇTollÑùÊÜÌ壨TLR£©7/8µÄÅäÌå¡£ÓÉÓÚTLRsÂþÑÜÓÚ¾ÞÊÉϸ°û¡¢µ¥ºËϸ°ûºÍ½¬Ï¸°ûÑùÊ÷ͻϸ°û£¨pDC£©ÉÏ£¬Òò´ËIMQÄܹ»Ç¿ÁÒ¼¤»îÃâÒßϵͳ¡£¾Ö²¿Ê¹ÓÃIMQ¿ÉÓÕµ¼Òøм²¡£¬Äܹ»½ÏºÃµØÄ£ÄâÈËÀàÒøм²¡ÑùµÄƤËðÌåÏÖ£¬²¢Ò»¶¨Ë®Æ½µØ±£´æÓëÒøм²¡ÏàËƵĹÌÓÐÃâÒߺͻñµÃÐÔÃâÒßÎÉÂÒ£¬¿ÉÓÃÓÚÑо¿Òøм²¡Ç±ÔÚ»úÖƺÍÆÀ¹ÀÐÂÁÆ·¨¡£
06 IL-23ÓÕµ¼µÄСÊó¶úÀªÒøм²¡Ä£ÐÍ
IL-23£¨°×ϸ°û½éËØ-23£©ÊÇÒ»ÖÖÒìÔ´¶þ¾ÛÌåϸ°ûÒò×Ó£¬ÓÉp19ÑÇ»ù£¨IL-23¶ÀÍÌ£©ºÍp40ÑÇ»ù£¨ÓëIL-12¹²Ïí£©Í¨¹ý¶þÁò¼üÁ¬½ÓÐγɡ£IL-23/Th17ͨ·ÊÇÒøм²¡µÄÖ÷ÒªÖ²¡Í¨Â·¡£IL-23Äܹ»Ôö½øTh17ϸ°ûµÄÆÊÎö£¬±¬·¢IL-17A¡¢IL-17F¼°IL-22µÈϸ°ûÒò×Ó£¬´Ó¶øµ¼Ö½ÇÖÊÐγÉϸ°ûÒì³£ÆÊÎöºÍÑ×Ö¢¡£ÆäÖУ¬IL-23/IL-17Aͨ·ÔÚÒøм²¡ÖÐÆð×ÅÖÁ¹ØÖØÒªµÄ×÷Óá£
IL-23×¢ÉäÄ£Ð͵ÄÓÅÊÆÔÚÓÚʹÓüòµ¥Ï¸°ûÒò×Ó£¬²¢ÇÒÕâÖÖϸ°ûÒò×ÓÔÚÒøм²¡ÖÐÒý·¢Ñ×Ö¢µÄ×÷ÓÃÒÑ»ñµÃ֤ʵ¡£¾Æ¤ÄÚ×¢ÉäIL-23¿ÉÒÔÓÕµ¼Ð¡Ê󱬷¢Òøм²¡ÑùƤ·ô²¡±ä£¬½¨Á¢±ã½ÝÇÒ±¾Ç®½ÏµÍ£¬±»¹ã·ºÓÃÓÚÈËÀàÒøм²¡Ñо¿¡£
07 ·ð²¨õ¥ÓÕµ¼µÄ¼±ÐÔʪÕîÑùÄ£ÐÍ
ÌØÓ¦ÐÔƤÑ×£¨Atopic Dermatitis, AD£©µÄÓÕÒòÅÓ´ó¶àÑù£¬ÆäÁÙ´²ÌåÏÖ°üÀ¨Æ¤·ô¸ÉÔʪÕîÑùƤË𣨰üÀ¨ºì°ß¡¢Éø³öºÍ½áð衢̦޺Ñù±äµÈ£©ÒÔ¼°¾çÁÒðþÑ÷µÈµÈ¡£Èç²»¼ÓÒÔ¿ØÖÆ£¬ÕâЩÑ×Ö¢·´Ó¦¿ÉÄÜ»áת±äΪ¸üÄÑÒÔ½â¾öµÄ¼²²¡¡£
Ä¿Ç°£¬ÌÇƤÖʼ¤ËØ¡¢·ÇçÞÌ忹Ñ×Ò©µÈÊÇ¿ØÖÆÑ×Ö¢µÄÊ×Ñ¡¡£µ«Àà¹Ì´¼Ò©ÎïʹÓò»µ±£¬»áÅãͬһ¶¨Ë®Æ½µÄ¸±×÷Óá£ËùÒÔ£¬¿ª·¢ÖÎÁÆÑ×Ö¢µÄÐÂÒªÁì¾ßÓÐÖØÒªµÄÁÙ´²ÒâÒå¡£
ÔÚɸѡDZÔÚ¿¹Ñ×Ò©Îïʱ£¬·ð²¨õ¥ÓÕµ¼µÄСÊóÄ£ÐÍ¿ÉÒԽϺõػ¹ÔÑ×Ö¢·´Ó¦£¬³£±»ÓÃÓÚÑо¿¿¹Ñ×Ò©ÎïÔÚÎÞ¾úÐÔÑ×Ö¢ÖеÄҩЧ¡£±ðµÄ£¬·ð²¨õ¥Ò²³£ÓÃÓÚ½¨Á¢¼±ÐÔʪÕîÑùÄ£ÐÍ¡£
08 DNFBÓÕµ¼µÄÑǼ±ÐÔʪÕîÑùÄ£ÐÍ
ÔÚÌØÓ¦ÐÔƤÑ×£¨AD£©Ñо¿ÖУ¬¿ÆÑÐÈËÔ±ÔøʵÑéͨ¹ý·Û³¾òý£¨Dermatophagoides farinae, Df/Derf£©×÷Ϊ¹ýÃôÔ½¨Á¢ADСÊóÄ£ÐÍ¡£µ«ÔÚBALB/cСÊóÉíÉϱíƤͿĨDfÌáÈ¡ÎDfE£©²¢Ã»ÓÐÓÕµ¼·ºÆðµä·¶µÄƤËð·´Ó¦¡£
2,4-¶þÏõ»ù·ú±½£¨Dinitrofluorobenzene, DNFB£©ÊÇÒ»ÖÖÄܵ¼ÖÂСÊó½Ó´¥ÐÔƤÑ׵ij£¼ûµ¥Ì壬ÄÜÓëƤ·ô×éÖ¯ÂÑ°×½áºÏ³ÉΪÍêÈ«¿¹Ô£¬¼¤»îTÁÜ°Íϸ°û£¬Òý·¢¹ýÃô·´Ó¦¡£DNFBÒý·¢µÄƤ·ô¹¦Ð§ÕÏ°¿ÉÄÜÊÇÔöÇ¿DfE¶ÔСÊóƤ·ôÓ°ÏìµÄÒ»ÖÖÒªÁì¡£
½»ÌæʹÓÃDNFBºÍDf´Ì¼¤Æ¤·ô£¬¿ÉÓÕµ¼BALB/cСÊ󱬷¢ÓëÈËÀàADÏàËƵÄTh2ÐÍƤ·ôÑ×Ö¢¡£ÕâÖÖÄ£ÐͶÔÑо¿ADµÄ·¢²¡»úÖƺͿª·¢ÐÂÐÍÖÎÁÆÒ©ÎïºÜÓмÛÖµ¡£
09 DNFBÓÕµ¼µÄÂýÐÔÌØÓ¦ÐÔƤÑ×Ä£ÐÍ
DNFB³£±»ÓÃÀ´½¨Á¢Ð¡ÊóÌØÓ¦ÐÔƤÑ×£¨AD£©Ä£ÐÍ£¬Ëæ×ÅÔìÄ£Àú³Ì·ºÆðƤ·ô¸ÉÔïÍÑм¡¢ºì°ßµÈÂýÐԸı䣬ÓëÈËÀàADƤËð±ä¸ïÏàËÆ¡£
ͨ¹ýDNFBÖظ´´Ì¼¤¿ÉÒÔ½¨Á¢ÂýÐÔÌØÓ¦ÐÔƤÑ×Ä£ÐÍ£¬ÓÕµ¼ADÑùƤÑס¢×é֯ѧ±ä¸ïÒÔ¼°±íƤÆÁÕϹ¦Ð§ÕÏ°£¬Ñо¿¾çÁÒðþÑ÷ºÍ¸´·¢ÐÔƤËðµÈÎÊÌâ¡£
10 TNBSÓÕµ¼µÄ´óÊóÀ£ÑñÐԽ᳦Ñ×Ä£ÐÍ
Ñ×Ö¢ÐÔ³¦²¡£¨Inflammatory bowel disease, IBD£©ÊÇÒ»ÖÖÂýÐÔ³¦µÀÑ×Ö¢ÐÔ¼²²¡£¬°üÀ¨¿ËÂÞ¶÷²¡£¨Crohn's Disease, CD£©ºÍÀ£ÑñÐԽ᳦Ñ×£¨Ulcerative Colitis, UC£©£¬Ä¿Ç°·¢²¡»úÖÆÉв»Ã÷È·£¬Ö÷ÒªÓëÃâÒßϵͳÒì³£¡¢´ó×Úϸ°û½þÈóÓйأ¬°üÀ¨CD4+ TÁÜ°Íϸ°û¡¢·Ê´óϸ°û¡¢ÖÐÐÔÁ£Ï¸°ûºÍÊÈËáÐÔÁ£Ï¸°ûÊýÁ¿Ôö¼Ó¡£ÕâЩÃâÒß·´Ó¦»áÒýÆðÑ×Ö¢¡¢À£Ññ¡¢Ë®Öס¢¸¹Ðº£¨ð¤Òº±ãºÍ/»òŧѪ±ã£©¡¢·¢ÈȺÍ賦È䶯ÕÏ°¡£ÁÙ´²»¹Ã»ÓÐÕë¶ÔIBDµÄÒ©ÎĿǰµÄÖ÷ÒªÖÎÁÆÒªÁìÊÇÑÓ»º¼²²¡½øÕ¹¡£
IBD¶¯ÎïÄ£ÐÍÄܹ»ÌåÏÖ³öÈËÀàCDºÍUCµÄijЩ²¡/ÉúÀíÌØÕ÷£¬°üÀ¨ÌåÖؼõÇáºÍ¸¹Ðº£¬°éÓÐѪ±ãºÍ/»òÕ³Òº±ã¡¢·¢ÈÈ¡¢½á³¦Ëõ¶Ì¡¢ÒþÎÑÒì³£¡¢Î¸È䶯ÕÏ°ºÍÑ×֢ϸ°û½þÈóµÈ¡£
2,4,6-ÈýÏõ»ù±½»ÇËᣨTNBS£©ÓÕµ¼µÄÄ£ÐÍÊÊÓÃÓÚСÊóºÍ´óÊó¡£TNBS´óÊóÀ£ÑñÐԽ᳦Ñ×ÊÇÒ»ÖÖÒÔCD4+ TÁÜ°Íϸ°û½þÈóΪÌØÕ÷µÄTh1ÐÍÑ×Ö¢£¬ÓëÈËÀàCDºÍUC¾ßÓÐÏàͬµÄÌØÕ÷¡£
11 ÆϾÛÌÇÁòËáÄÆÓÕµ¼µÄСÊóÀ£ÑñÐԽ᳦Ñ×Ä£ÐÍ
ÆϾÛÌÇÁòËáÄÆ£¨Dextran sulphate sodium, DSS£©ÊÇÒ»ÖÖË®ÈÜÐÔ¡¢´ø¸ºµçºÉ¡¢·Ö×ÓÁ¿¿É±äµÄÁòËữ¶àÌÇ¡£ÓÉÓÚDSS¶Ô½á³¦ÉÏƤϸ°ûÓж¾ÐÔ£¬¿ÉÄܵ¼ÖÂճĤÆÁÕϹ¦Ð§ÊÜËð£¬Òò´Ë¸øСÊóÒûÓÃDSS¿ÉÒÔÒýÆðÀàËÆÈËÀà¿Ë¡¶÷Êϲ¡µÄÈ«½á³¦²¡Ö¢¡£
DSS½á³¦Ñ×Ä£Ð;¼Ã¡¢¼ò±ã£¬¿É´ó×ÚÖظ´½¨Á¢£¬ÔÚIBDÑо¿ÖкÜÊÇÁ÷ÐС£Í¨¹ý¸Ä±äDSSµÄŨ¶ÈºÍÒûÓÃƵÂÊ£¬¿ÉÒÔ½¨Á¢¼±ÐÔ¡¢ÂýÐԺ͸´·¢ÐÔ³¦Ñ×Ä£ÐÍ¡£
²Î¿¼ÎÄÏ×£º
[1] Jing Luan, et al. Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review). Exp Ther Med. 2021 Sep;22(3):939. doi: 10.3892/etm.2021.10371.
[2] Xin Cui, et al. Evaluation of antiarthritic activity of nimbolide against Freund's adjuvant induced arthritis in rats. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3391-3398. doi: 10.1080/21691401.2019.1649269.
[3] Su-Hyun Shin, et al. 1-Palmitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol (PLAG) Mitigates Monosodium Urate (MSU)-Induced Acute Gouty Inflammation in BALB/c Mice. Front Immunol. 2020 Apr 24:11:710. doi: 10.3389/fimmu.2020.00710.
[4] Cris S Constantinescu, et al. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011 Oct;164(4):1079-106. doi: 10.1111/j.1476-5381.2011.01302.x.
[5] Leslie van der Fits, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009 May 1;182(9):5836-45. doi: 10.4049/jimmunol.0802999.
[6] Shujing Feng, et al. An Atopic Dermatitis-Like Mouse Model by Alternate Epicutaneous Application of Dinitrofluorobenzene and an Extract of Dermatophagoides Farinae. Front Med (Lausanne). 2022 Jun 15:9:843230. doi: 10.3389/fmed.2022.843230.
[7] Benoit Chassaing, et al. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014 Feb 4:104:15.25.1-15.25.14. doi: 10.1002/0471142735.im1525s104.